AI-based lung nodule diagnosis and follow-up study
Part of Cancer, Lungs & breathing clinical trials.
This study uses artificial intelligence (AI) to help doctors analyze lung nodules seen on CT scans, with the goal of improving diagnosis and follow-up. It may help people who have a lung nodule that needs monitoring or clarification.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have at least one non-calcified lung nodule (between 3 mm and 30 mm) seen on a CT scan of your chest.
- You must be willing and able to give written informed consent.
- You must not have had lung cancer in the past on the same side of your chest (ipsilateral) or any local treatment for it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if artificial intelligence (AI) can accurately read CT scans of lung nodules (spots on the lung) to tell if they are cancer. Your participation helps improve diagnosis and may lead to better care.
This study tests whether an AI-based digital tool can help manage follow-up care for people with high-risk lung nodules (spots on the lung). It aims to improve monitoring and early detection of lung cancer.
This trial tests whether using AI to help radiologists read lung CT scans can find cancer earlier and lower healthcare costs. You may qualify if you are at risk for lung cancer and have not been screened recently.
This study uses artificial intelligence to analyze CT scans of lung nodules that look like ground glass, which may be early signs of cancer. The goal is to predict how these nodules will grow over time, helping doctors decide whether to monitor or treat them.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
This study uses artificial intelligence to analyze CT scans and other health data to better identify people at risk for smoking-related diseases like lung cancer. Researchers hope to improve early detection and prevention.
Hear when a new Pulmonary Nodules trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.